[CUE] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 26.59%
YoY- 44.34%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 68 2,395 704 984 449 0 0 -
PBT -10,955 -12,992 -10,031 -6,990 -12,559 -5,032 -2,024 32.48%
Tax -76 2 -123 -99 -102 0 0 -
NP -10,879 -12,993 -10,031 -6,990 -12,559 -5,032 -2,024 32.33%
Tax Rate - - - - - - - -
Total Cost 10,947 15,388 10,735 7,974 13,008 5,032 2,024 32.47%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -15,998.53 -542.51 -1,424.86 -710.37 -2,797.10 0.00 0.00 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.31 -0.41 -0.34 -0.31 -0.62 -0.24 -0.10 20.74%
EPS Diluted -0.31 -0.41 -0.34 -0.31 -0.62 -0.24 -0.10 20.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.